Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula

Get In Touch

Quick Email
info.help@gmail.com
  • Home |
  • Abivax rebounds from stock drop with safety data for much-hyped colitis prospect

Abivax rebounds from stock drop with safety data for much-hyped colitis prospect

  • June 30, 2026

Abivax has recovered from a dent in its share price after unveiling fresh safety data that appeared to ease investors’ concerns with its ulcerative colitis prospect.

Leave A Comment

Fields (*) Mark are Required